Biopharmaceuticals Producer Discovers Opportunity in Obsolescence Aging equipment has the potential to manifest into a multimillion- dollar issue for biopharmaceutical companies if not addressed. If the equipment were to experience a failure with no available spare parts, the production of high-value biological products would come to a costly halt and possibly also result in lost batches. One biopharmaceutical giant recently needed to address obsolescence in two of its purification skids, and saw it as an opportunity to make some additional operational improvements in the process. Staying Ahead of Obsolescence Each production batch begins with a 1 to 4 milliliter ampule of cells that serves as the powerhouse for creating key proteins in their drugs. Challenge Aging skid control systems f

Join for free to read